Ditchcarbon
  • Contact
  1. Organizations
  2. Sanofi Pasteur Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 9 months ago

Sanofi Pasteur Inc. Sustainability Profile

Company website

Sanofi Pasteur Inc., a leading global player in the vaccine industry, is headquartered in the United States and operates extensively across North America and beyond. Founded in 2004, the company has established itself as a key subsidiary of Sanofi, focusing on the research, development, and production of innovative vaccines that protect against infectious diseases. With a diverse portfolio that includes vaccines for influenza, meningitis, and polio, Sanofi Pasteur is renowned for its commitment to public health and safety. The company’s unique approach combines cutting-edge technology with rigorous scientific research, ensuring high-quality products that meet the evolving needs of healthcare providers and patients alike. Recognised for its significant contributions to immunisation efforts worldwide, Sanofi Pasteur holds a prominent market position, continually striving to enhance vaccine accessibility and effectiveness.

DitchCarbon Score

How does Sanofi Pasteur Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

100

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Sanofi Pasteur Inc.'s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

100%

Let us know if this data was useful to you

Sanofi Pasteur Inc.'s reported carbon emissions

Inherited from Sanofi

Sanofi Pasteur Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Sanofi, it inherits climate commitments and reduction targets from its parent company. Sanofi has engaged in various initiatives aimed at reducing carbon emissions, including participation in the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, which focuses on transitioning to 100% renewable energy. While specific reduction targets for Sanofi Pasteur Inc. are not detailed, the overarching commitments from Sanofi indicate a strong focus on sustainability and climate action. The company is actively working towards significant emissions reductions across its operations, aligning with industry standards and best practices in climate management. As of now, there are no reported achievements or specific numbers related to emissions reductions for Sanofi Pasteur Inc. However, the commitment to sustainability and climate initiatives reflects a proactive approach to addressing climate change within the pharmaceutical industry.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20102011201220132015201920202021202220232024
Scope 1
545,114,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
677,549,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
00,000,000
Scope 3
-
-
-
0,000,000,000
-
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

How Carbon Intensive is Sanofi Pasteur Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Sanofi Pasteur Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Sanofi Pasteur Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Sanofi Pasteur Inc. is in US, which has a low grid carbon intensity relative to other regions.

Sanofi Pasteur Inc.'s Scope 3 Categories Breakdown

Sanofi Pasteur Inc.'s Scope 3 emissions, which decreased by 5% last year and increased by approximately 40% since 2013, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 69% of Scope 3 emissions.

Top Scope 3 Categories

2024
Purchased Goods and Services
69%
End-of-Life Treatment of Sold Products
5%
Capital Goods
5%
Business Travel
4%
Upstream Transportation & Distribution
4%
Waste Generated in Operations
3%
Fuel and Energy Related Activities
3%
Employee Commuting
3%
Use of Sold Products
2%
Investments
<1%

Sanofi Pasteur Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Sanofi Pasteur Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Sanofi Pasteur Inc.'s Emissions with Industry Peers

Pfizer Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Sanofi Pasteur MSD GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Merck Sharp & Dohme LLC

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Csl

AU
•
Pharmaceutical Preparation Manufacturing
Updated 22 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251211.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy